2026-05-08
Cerebras hikes IPO range to $125–$135 as orders hit ~$10B against $3.5B on offer
Cerebras hikes IPO range to $125–$135 as orders hit ~$10B vs $3.5B on offer. Implied valuation comfortably above $26.6B; CBRS prices May 13.
Bloomberg reported on May 8, 2026 that Cerebras Systems is raising its Nasdaq IPO price range from the original $115–$125 to $125–$135 per share. Banks are fielding roughly $10 billion in orders against just $3.5 billion on offer — over 20× oversubscribed. The deal pushes implied valuation comfortably past $26.6 billion when CBRS prices on May 13.
What’s in the offering
The base deal is 28 million Class A shares, plus a 4.2 million underwriter option (greenshoe). The S-1/A discloses ~$510M in 2025 revenue (up from $290M in 2024) and a multi-year, $20B+ compute commitment from OpenAI for 750 megawatts of inference capacity running through 2028.
The book is dominated by long-only mutual funds and sovereign wealth funds — typically a sign that pricing will land at the high end and traders should expect a tight float on day one.
What changed since the May 4 filing
Three things drove the price hike:
- The OpenAI compute deal disclosure expanded from “multi-year” to a quantified $20B+ commitment with named MW capacity.
- Anthropic-SpaceX Colossus deal (May 6) validated the thesis that hyperscaler-scale dedicated inference capacity is now a real product category with bookable demand.
- NVIDIA’s H200/B200 supply remained tight through Q1 2026 earnings, leaving room for an alternative inference vendor with binding hyperscaler commitments.
What to watch at pricing
- Allocation discipline. If the deal prices at $135 with a tight float, retail demand on Nasdaq day one likely creates a 30–50% pop. Long-term holders won’t sell into that; flippers will.
- Lock-up expiry math. Insider lock-up runs 180 days. The first big supply uncork lands in November 2026, near the next earnings cycle.
- OpenAI dependency. ~85% of 2025 revenue comes from one customer. The S-1/A flags this as the principal risk; watch for diversification announcements between IPO and Q3 2026 earnings.
Practitioner note
For infrastructure decisions: this changes Cerebras from “interesting research bet” to “vendor with public-market permanence and a $20B OpenAI backlog.” If you route latency-sensitive inference (real-time voice, live coding agents, interactive translation), the case for benchmarking your actual workload on Cerebras Inference cloud just got stronger — the company isn’t going anywhere for at least three years. Action item: spend $5–$10 of API credit comparing Cerebras Inference vs your current H100/H200 baseline on your top three latency-sensitive endpoints, before post-IPO hype makes the data noisier.
Sources
- Cerebras plans to raise IPO price range — Bloomberg ↗
- Cerebras on track for blockbuster IPO — TechCrunch ↗
- Cerebras IPO pricing — CNBC ↗